CommentaryHealth Policy

Whole-Genome Sequencing in Newborn Screening Programs

Science Translational Medicine  26 Mar 2014:
Vol. 6, Issue 229, pp. 229cm2
DOI: 10.1126/scitranslmed.3008494

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The availability of whole-genome sequencing (WGS) is likely to change the practice of population screening programs such as newborn screening (NBS). This Commentary raises key ethical, legal, and social issues surrounding WGS in NBS and suggests a need for deliberation regarding the policy challenges of introducing sequencing in such programs. Any change in the goals of NBS programs should be discussed carefully and should represent the best interests of the child.

View Full Text